Marchex FY2025 adjusted EBITDA loss widens to $0.7 million; revenue falls 5.6% to $45.4 million

Reuters
Yesterday
<a href="https://laohu8.com/S/MCHX">Marchex</a> FY2025 adjusted EBITDA loss widens to $0.7 million; revenue falls 5.6% to $45.4 million
  • Marchex published an earnings release reporting Q4 and FY 2025 results, with Q4 GAAP revenue of USD 10.8 million, down 9.02%.
  • FY 2025 GAAP revenue was USD 45.4 million, down 5.61%.
  • Q4 net loss applicable to common stockholders was USD 2.3 million, a 21.36% wider loss, and adjusted EBITDA was a loss of USD 1.2 million.
  • FY net loss applicable to common stockholders was USD 5.2 million, a 5.82% wider loss, and adjusted EBITDA was a loss of USD 748,000.
  • Troy Hartless said the company largely completed its technology platform migration, which involved moving about 1,000 customers and contributed to revenue dilution, and Marchex guided for Q1 2026 revenue to be in the range of Q4 2025 levels with adjusted EBITDA of USD 500,000 or more.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Marchex Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202603251615BIZWIRE_USPR_____20260325_BW485154) on March 25, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10